Skip to main content
OpenTrials
Completed

NCT Number: NCT00536926

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation

In an investigation should be evaluated in contrast to a control group with standard post-treatment therapy (using home spirometry) after lung transplantation if transfer of home spirometry recordings to the transplant center via cell phones will lead to less complications, cost savings and bigger constancy of therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Hannover Medical School, Dpt. resiratory Medicine OE6870

Hanover, 30625, Germany

About this study

Home spirometry is used as a standard of care in lung transplant recipients in many centers worldwide. In case of deteriorating lung function response until therapy depends on patients efforts to reach the transplant center and the contactability of the transplant center.

Therefore transfer of home spirometry recordings to the transplant center via cell phones will lead to less complications, cost savings and bigger constancy of therapy compared to the home spirometry alone.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients after lung transplantation (single and double lung transplantation incl. combined organ transplantation) before hospital discharge

Exclusion criteria

  • Dependency on long term care
  • Restricted ability to communicate

Treatment and study plan

Home spirometry with data transfer via cell phone

Device

home spirometry recording

Other names: Viasys AM1 /group A, Viasys AM1+BT/ group B

Home spirometer with BT-cellphone

Device

Data transfer of home spirometry recordings via bluetooth to clinical database.

Other names: Viasys AM1 BT (Jaeger, Germany) with BT-cellphone

Home spirometer w/o BT

Device

Standard home spirometry

Other names: Viasys (Jaeger, Germany) AM1

Primary outcomes

  1. Adherence

    Time frame: 6 months

Secondary outcomes

  1. Latency: symptom onset to transplant team contact patient contacts emergency visits hospitalisations

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Hannover Medical School

Other

Collaborators

  • Corscience, Inc.

Registry information

Official study title

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation - an Open, Randomised Trial

Acronym: TeleTx

Important dates

Study start
2007
Primary completion
2008
Study completion
2009
First posted
Sep 28, 2007
Registry last updated
Jul 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.